24 July 2023
24 July 2023
BlueRiver and Spinal Stabilization Technologies will enter a business combination agreement and list on an approved stock exchange.
The new scanner is being developed to identify lung diseases at an earlier stage.
The funding will allow the corporation to expand its commercial launch to three additional US regions.
The updated product is claimed to be the only system with a centralised user interface for up to four modules.
The assay helps detect internal tandem duplication and tyrosine kinase domain mutations D835 and I836 in the FLT3 gene.
The company will use the funds to grow access to its platform and expand into more US states.
Each week, Medical Device Network journalists explore movements in job postings that shed light on hiring trends in our sector.
The launch of the new analyser comes after it received approval from the US FDA.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
